STCBIO

Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!

March 11, 2020NewsBy stcbio

STRI (Stem Cell Treatment & Research Institute) Registered a US Patent for its Newly Elicited Pluripotent Stem Cell without Side Effects by Natural Compounds (nEPS)

[약업신문] 2019, 03.13

STRI (Stem Cell Treatment & Research Institute) Registered a US Patent for its Newly Elicited Pluripotent Stem Cell without Side Effects by Natural Compounds (nEPS)
It can be differentiated into all the tissues and organs… Applicable to the treatment of incurable diseases.

View Detail: https://www.yakup.com/news/index.html?mode=view&cat=12&nid=228143

BACK

No title
July 31, 2020

STRI PERFECTS STEM-CELL PLURIPOTENCY TO ENABLE 3D PRINTING OF HUMAN ORGANS
April 17, 2020

460 patents regarding nEPS are registered in 147 countries.
March 19, 2020

STRI registered a patent for liver cell differentiation using the world’s first pluripotent stem cells without side effects (nEPS) at EU
March 11, 2020

STRI achieved a patent for ‘liver cell differentiation using newly Elicited Pluripotent Stem Cells without side effects using natural compounds(nEPS)’ at EU
March 11, 2020

bBHC achieved a patent for ‘liver cell differentiation using newly Elicited Pluripotent Stem Cells without side effects by natural compounds(nEPS)’ in the EU followed by Korea, America, and Australia.
March 11, 2020